Scientific Advisory Board
The miGut-Health advisory board brings together actors with different backgrounds and interests. They are closely involved throughout the duration of the project by providing expert advice and guidance. Their input is invaluable in shaping the overall direction and lasting success of the project.
The advisory board consists of four members:
Professor Dr Vibeke Andersen
IBD researcher and gastroenterologist
Professor Dr Tom Hemming Karlsen
gastroenterologist/hepatologist with expertise in biomarker research
Professor Dr Mauro D’Amato
scientist and expert on gut health/biological research
Professor Dr Konstantinos Gerasimidis
clinical nutrition specialist for IBD
The miGut-Health research and related activities are overseen by an Independent Ethics Advisor to ensure compliance with ethical principles and relevant legislation, including the EU Charter of Fundamental Rights and the European Convention on Human Rights. The miGut-Health ethics advisor is consulted during the preparation of all deliverables involving ethical aspects and provides guidance to the consortium on ethically sensitive matters and activities.
Professor Dr Robert Ranisch
Junior Professor of Medical Ethics at the Faculty of Health Sciences Brandenburg, University of Potsdam, and Head of the research unit "Ethics of Genome Editing" at the Institute for Ethics and History of Medicine, University of Tübingen, Germany